Sol-Gel to acquire rare disorder drug patidegib for $4.7M upfront; plans $22.8M offerings
Click HERE to view the article on Seeking Alpha. The [...]
Hedgehog Inhibitor Therapy’s Use in Advanced Basal Cell Carcinoma – Does It Work?
Click HERE to view the article on Dermatology Times. The [...]
Experts Review Treatments, Directions in Basal Cell Carcinoma
Click HERE to view the article on Pharmacy Times. The [...]
Dr. Contreras on Neoadjuvant Therapies in Basal Cell Carcinoma and Cutaneous Squamous Cell Carcinoma
Click HERE to view this article on OncLive. The Gorlin [...]
Hedgehog Pathway Inhibitors Market Size Trends Insights | Japan | China | 2022
Click HERE to view the article on OpenPR. The Gorlin [...]
Hedgehog Pathway Inhibitors Market to Expand at a Notable CAGR of ~11.1% Assessment for the Driving Factors, Size, Revenue, Segments, Expansion, Demand, and Opportunities During 2023-2033
Click HERE to view the article on Digital Journal. The [...]
Hamid Reviews Options for Patients With Basal Cell Carcinoma and Cutaneous Squamous Cell Carcinoma
Click HERE to view the article on Targeted Oncology. The [...]
Expression of Hedgehog Signaling Pathway Proteins in Basal Cell Carcinoma: Clinicopathologic Study
Click HERE to view the article on the Dove Press. The [...]
Treating Skin Cancers in the Immunotherapy Era
Click HERE to view the article on Dermatology Times. The [...]
Sonidegib, a Hedgehog Signaling Pathway Inhibitor for Locally Advanced Basal Cell Carcinoma
Click HERE to view the article on Pharmacy Times. The [...]